Company intelligence / Profile preview
Odyssey Group International
Las Vegas, Nevada, United Statesodysseygi.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Odyssey Group International—now operating as Odyssey Health, Inc.—is developing novel pharmaceuticals and medical devices targeting neurological conditions and emergency medicine. Its lead program ONP/PRV/ONP‑002 for concussion has completed Phase I single ascending dose studies with positive safety results and demonstrated preclinical efficacy in animal models of brain injury. The company also has a rare disease program for Niemann-Pick disease in preclinical or early development stages[8][9][10].
- Therapeutic areas
- Neurology
- Modalities
- Small molecules (neurosteroids)Medical devices
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Odyssey Group International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Odyssey Group International.